|
Neuland Laboratories Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
27499.58 Cr.
|
P/BV
|
14.67
|
Book Value (Rs.)
|
1,460.97
|
|
52 Week High/Low (Rs.)
|
20099/11500
|
FV/ML
|
10/1
|
P/E(X)
|
75.55
|
|
Bookclosure
|
24/07/2026
|
EPS (Rs.)
|
283.71
|
Div Yield (%)
|
0.16
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 488.98 | 346.33 | 401.44 | 215.75 | 82.16 |
| | | | | | |
| Net CashFlow From Operating Activities | 346.68 | 317.38 | 261.18 | 237.21 | 58.58 |
| Net Cash Used In Investing Activities | -423.73 | -298.16 | -149.69 | -61.50 | -93.71 |
| Net Cash Used From Financing Activities | 20.98 | 24.96 | -69.28 | -135.80 | 37.72 |
| Foreign Exchange Gains / Losses | 0.82 | 0.17 | -0.05 | 0.41 | 0.06 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -55.26 | 44.36 | 42.16 | 40.32 | 2.66 |
| Cash And Cash Equivalents Begin of Year | 131.93 | 87.58 | 45.42 | 5.09 | 2.44 |
| Cash And Cash Equivalents End Of Year | 76.67 | 131.93 | 87.58 | 45.42 | 5.09 |